Related Experiment Video
Updated: Apr 26, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Health-related quality of life in preschool children with Type 1 diabetes
F Sundberg1, P Sand, G Forsander
1Diabetes Unit, The Queen Silvia Children's Hospital/Sahlgrenska University Hospital, Gothenburg, Sweden; Department of Paediatrics, Institution of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Insights
Very young children with Type 1 diabetes mellitus experience lower health-related quality of life compared to healthy peers. This highlights the need for quality of life screening in all children with diabetes.
Area of Science:
- Pediatrics
- Endocrinology
- Quality of Life Research
Background:
- Type 1 diabetes mellitus (T1DM) is a chronic condition affecting children.
- Assessing health-related quality of life (HRQoL) is crucial for understanding the holistic impact of T1DM in pediatric populations.
- Limited data exists on HRQoL in very young children (<7 years) with T1DM.
Purpose of the Study:
- To compare HRQoL in children under 7 years with T1DM versus healthy controls.
- To examine correlations between HRQoL and insulin treatment/glycemic control in children with T1DM.
Main Methods:
- A cohort of 24 children with T1DM (mean age 4.5) and 27 healthy children (mean age 4.6) participated.
- Participants completed the Pediatric Quality of Life Inventory 4.0 Generic Core Scales.
- Children with T1DM also completed the Pediatric Quality of Life Inventory 3.0 Type 1 Diabetes Module, with HbA1c and glucose meter data collected.
Main Results:
- Children with T1DM had significantly lower parent-rated generic HRQoL scores (80 vs 91, P=0.003) compared to healthy children.
- The disparity was more pronounced in children under 5 years (79 vs 93, P=0.004).
- 22% of parents of children with T1DM rated their child's HRQoL as a concern; 40% of children aged 5-7 with T1DM rated their own HRQoL similarly.
Conclusions:
- Very young children with T1DM exhibit a significantly reduced generic HRQoL compared to healthy peers.
- The findings support the recommendation for routine HRQoL screening in all children diagnosed with T1DM, irrespective of age.
Aims:
To describe health-related quality of life in children aged < 7 years with Type 1 diabetes mellitus compared with healthy children of the same age, and to investigate how health-related quality of life was correlated with aspects of insulin treatment and glycaemic control.
Methods:
The participants in this study were 24 children with diabetes (12 girls, mean age 4.5 years) and 27 healthy children (14 girls, mean age 4.6 years). All participants completed the Pediatric Quality of Life Inventory 4.0 Generic Core Scales and the participants with diabetes also completed the Pediatric Quality of Life Inventory 3.0 Type 1 Diabetes Module Scales. HbA1c levels were measured in children with diabetes and the plasma glucose meter memories were uploaded.
Results:
Children aged <7 years with diabetes had lower parent-rated generic health-related quality of life compared with healthy children (score: 80 vs 91; P = 0.003). The difference was largest in children aged < 5 years (score: 79 vs 93; P = 0.004). Among the parents of children with Type 1 diabetes, 22% rated their child's generic health-related quality of life to be at a level of concern (- 1 sd of a general population). Of the children with Type 1 diabetes aged between 5 and 7 years, 40% rated their own generic health-related quality of life at the same level of concern.
Conclusion:
This study shows a significantly lower level of generic health-related quality of life in very young children with diabetes in comparison with healthy children. We suggest screening for health-related quality of life in children of all ages with Type 1 diabetes mellitus.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes III: Clinical Manifestations
Type I Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Type I Diabetes II: Pathophysiology
